NCT07162935 (CLARITY) is a NA clinical trial of Cigarillo brand 1 in Cigar Smoking, sponsored by University of Oklahoma.

Who is sponsoring NCT07162935?

NCT07162935 is sponsored by University of Oklahoma.

What drugs are being tested in NCT07162935?

Interventions in NCT07162935: Cigarillo brand 1, Cigarillo brand 2, Cigarillo brand 3.

What condition does NCT07162935 study?

NCT07162935 studies Cigar Smoking, Tobacco Use.

Is NCT07162935 still recruiting?

NCT07162935 is currently recruiting now. Last updated 14 April 2026.

Last reviewed 2026-04-14 · How we verify

NCT07162935: CLARITY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)

Recruiting now NA Last updated 14 April 2026

What this trial tests

NA trial testing Cigarillo brand 1 in Cigar Smoking in 300 participants. Currently enrolling.

Timeline

23 February 2026

Primary endpoint
2 March 2030

31 May 2030

Quick facts

Lead sponsor	University of Oklahoma
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	300
Start date	23 February 2026
Primary completion	2 March 2030
Estimated completion	31 May 2030
Sites	2 locations across United States

Drugs / interventions tested

Cigarillo brand 1
Cigarillo brand 2
Cigarillo brand 3

Conditions studied

Cigar Smoking — all drugs for Cigar Smoking →
Tobacco Use — all drugs for Tobacco Use →

Sponsor

University of Oklahoma

Who can join

Adults 18 to 24, any sex, with Cigar Smoking or Tobacco Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial will recruit young adults who currently use cigarillos and examine the smoking behavior and perceptions of different flavored cigarillos, product ingredients/additives impacting these perceptions, and simulated tobacco use outcomes (quitting, switching) in various policy scenarios where different types of flavors are available on the market.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07162935 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 14 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07162935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing